Abstract | BACKGROUND: MATERIAL AND METHODS: We conducted a retrospective search of the prospectively maintained Royal Marsden Hospital Sarcoma Unit database to identify patients with AF treated with chemotherapy between 1987 and 2009. RESULTS: Thirty-nine patients, thirty one females and eight males, received one or more lines of chemotherapy. The most frequently employed chemotherapy regimens were methotrexate/ vinblastine [MTX/VBL] (18) and pegylated liposomal doxorubicin [ PLD] (14). MTX/VBL was administered weekly or every two weeks at MTX 50 mg and VBL 10 mg. Treatment duration ranged from three weeks to one year with a median of 4.5 months. Partial response (PR) was observed in 11% of cases, disease stabilisation (SD) in 60% and progressive disease (PD) in 22%. Time to progression ranged from one month to sixteen years. The main toxicities reported were mucositis (4), peripheral neuropathy (3), vomiting (3), and neutropenia (3). PLD was administered at 40-50 mg/m(2) every four weeks, for up to six cycles. PR was achieved in 33% and in the remainder the disease was stable with no progression during treatment. Three (25%) patients have so far progressed after treatment. Symptomatic benefit, especially pain relief, was reported in 86% (12/14) of cases. Main toxicities included palmar plantar erythema (5) and mucositis (4). DISCUSSION: MTX/VBL remains a useful combination but PLD is emerging as a well tolerated and effective systemic therapy in advanced AF.
|
Authors | Anastasia Constantinidou, Robin L Jones, Michelle Scurr, Omar Al-Muderis, Ian Judson |
Journal | Acta oncologica (Stockholm, Sweden)
(Acta Oncol)
Vol. 50
Issue 3
Pg. 455-61
(Apr 2011)
ISSN: 1651-226X [Electronic] England |
PMID | 20799916
(Publication Type: Evaluation Study, Journal Article)
|
Chemical References |
- liposomal doxorubicin
- Polyethylene Glycols
- Vinblastine
- Doxorubicin
- Methotrexate
|
Topics |
- Abdominal Neoplasms
(diagnostic imaging, drug therapy, pathology)
- Adolescent
- Adult
- Antineoplastic Combined Chemotherapy Protocols
(therapeutic use)
- Child
- Child, Preschool
- Disease Progression
- Doxorubicin
(administration & dosage, analogs & derivatives)
- Female
- Fibromatosis, Aggressive
(diagnostic imaging, drug therapy, pathology)
- Humans
- Male
- Methotrexate
(administration & dosage)
- Middle Aged
- Neoplasm Invasiveness
- Palliative Care
(methods)
- Polyethylene Glycols
(administration & dosage)
- Radiography
- Registries
(statistics & numerical data)
- Retrospective Studies
- Treatment Outcome
- Vinblastine
(administration & dosage)
- Young Adult
|